Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losmapimod outcomes study in acute coronary syndrome
2013-000657-50Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Losmapimod + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Primary efficacy endpoint. Started Feb 2014; status: completed.
02
Drugs
losmapimod
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2013-000657-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000657-50.